# Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation

> **NCT01610999** · PHASE1 · TERMINATED · sponsor: **Tufts Medical Center** · enrollment: 7 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia
- Lymphoma
- Multiple Myeloma

## Interventions

- **DRUG:** Plerixafor

## Key facts

- **NCT ID:** NCT01610999
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2014-06
- **Final completion:** 2015-12
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Unavailability of study article
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01610999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01610999, "Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01610999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*